Heterogeneous CD3 Expression Levels in Differing T Cell Subsets Correlate with the In Vivo Anti-CD3–Mediated T Cell Modulation-Reference-Cited by-同舟云学术

Heterogeneous CD3 Expression Levels in Differing T Cell Subsets Correlate with the In Vivo Anti-CD3–Mediated T Cell Modulation

Published:2015-02-02 Issue:5 Volume:194 Page:2117-2127
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Valle Andrea,Barbagiovanni Giulia,Jofra Tatiana,Stabilini Angela,Perol Louis,Baeyens Audrey,Anand Santosh,Cagnard Nicolas,Gagliani Nicola,Piaggio Eliane,Battaglia Manuela

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?

2. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

3. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.;Chatenoud;J. Immunol.,1997

4. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

5. Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance;Transplantology;2024-07-29

2. Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy;Molecular Therapy - Nucleic Acids;2023-12

3. Tolerogenic dendritic cells in type 1 diabetes: no longer a concept;Frontiers in Immunology;2023-06-14

4. Condyloma acuminata: An evaluation of the immune response at cellular and molecular levels;PLOS ONE;2023-04-13

5. Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C+CD57+NK and δ2-γδT cell subsets;Frontiers in Immunology;2022-12-01